Endologix recently announced that it has received US Food and Drug Administration (FDA) approval for a premarket approval (PMA) supplement relating to the AFX2 system. According to a company press release, Endologix received approval to include an updated warning and the most contemporary clinical information in the labelling for the AFX2 system. Clinical data added […]
The post Endologix receives US FDA approval of PMA supplement for AFX2 system appeared first on Vascular News.